Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 16 Projects
Project # Contact PI Funding Organization Fiscal Year
Testing low-dose efavirenz treatment for Alzheimer’s disease: a phase 1b dosing, target-engagement and exploratory biomarker study.
ADDF-48 SCHELTENS, PHILIP Alzheimer's Drug Discovery Foundation 2021
Understanding ROS-induced lipopathology downstream of sporadic AD risk gene
2019-AARG-643165 VAN DER KANT, Rik Alzheimer's Association 2019
Resolving Alzheimer disease by Resilience Multiscale Models (ARMS)
GEENA-Q-19-595225 Olde Rikkert, Marcel Alzheimer's Association 2019
Impact of (p-)Tau and amyloid-ß on brain networks in Alzheimer patients
AARF-18-566459 Jonkman, Laura Alzheimer's Association 2018
A Phase IIa Trial to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of TW001 in Alzheimer Patients
GC-2013807 van der Geest, Ronald Alzheimer's Drug Discovery Foundation 2018
Seeding disease: how pathological tau meets endogenous tau.
AARG-17-498856 van Weering, Jan Alzheimer's Association 2017
Gait dysfunction as a pre-clinical sign of Alzheimer disease
2014-NIRG-305710 IKRAM, MOHAMMAD ARFAN Alzheimer's Association 2014
Novel diagnostic CSF biomarkers for pathological subtypes of FTD
20141204-Teunissen-2014 Teunissen, Charlotte Alzheimer's Drug Discovery Foundation 2014
Amyloid beta targets synapses based on AMPA receptor subunit composition
NIRP-12-257089 KESSELS, HELMUT Alzheimer's Association 2013
Age-dependent Toll-like receptor signalling in AD brain
NIRG-12-241286 HOOZEMANS, JEROEN Alzheimer's Association 2012